Approval · Notice of Compliance 20701 · 2018
OCEANBLU: Notice of Compliance 20701
Issued March 28, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20701
- Date
- March 28, 2018
- Company
- DeLaval, Inc.Ville D'Anjou, Quebec, Canada
- Product type
- Veterinary
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OCEANBLU | 02474301 | Marketed |
Medicinal ingredients
- GLYCOLIC ACID 3 PER